Search - tctmd.com

Displaying 141 - 160 of 229

Presentation TCT 2017

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR)

Presenter: Daniel Burkhoff, Samir R. Kapadia, Stephen G. Worthley

November 01, 2017

$First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease$

Presentation TCT 2017

First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease

Presenter: Daniel Burkhoff, Samir R. Kapadia, Alaide Chieffo

November 01, 2017

Presentation TCT 2017

Future Devices for Mechanical Circulatory Support in Cardiogenic Shock and High-Risk PCI

Presenter: Navin K. Kapur, Jeffrey W. Moses, Ulrich P. Jorde

October 31, 2017

Presentation TCT 2017

Novel Access Approaches for Percutaneous Maximal Circulatory Support Devices: Transcaval and Subclavian/Axillary Advancements

Presenter: Navin K. Kapur, Jeffrey W. Moses, James M. McCabe

October 31, 2017

Presentation TCT 2017

Mechanical Support Mishaps! Lessons Learned From Complications With Use of Mechanical Circulatory Support

Presenter: Navin K. Kapur, Jeffrey W. Moses, Sanjog Kalra

October 31, 2017

Presentation TCT 2017

An Algorithm for Mechanical Circulatory Support

Presenter: Navin K. Kapur, Jeffrey W. Moses

October 31, 2017

Presentation TCT 2017

Flash Perspectives: ECMO and ECMO Circuit Modifications Are the Best Methods to Achieve True Maximal Circulatory Support During High-Risk PCI!

Presenter: Navin K. Kapur, Jeffrey W. Moses, Hiroo Takayama

October 31, 2017

Presentation TCT 2017

Flash Debate: The Impella Series of Devices Is the Current Gold Standard for Mechanical Support During High-Risk PCI!

Presenter: Navin K. Kapur, Jeffrey W. Moses, Jonathan M. Hill

October 31, 2017

Presentation TCT 2017

Flash Debate: An IABP Is Really All the Circulatory Support a Good Interventionalist Needs for Almost All Cases of High-Risk PCI!

Presenter: Navin K. Kapur, Jeffrey W. Moses, Gert Richardt

October 31, 2017

Presentation TCT 2017

When Should Hemodynamic Support Be Used During PCI?

Presenter: Navin K. Kapur, Jeffrey W. Moses, Francesco Burzotta

October 31, 2017

Presentation TCT 2017

Diagnosis and Treatment Options for RV Shock

Presenter: Vladimir Dzavik, Navin K. Kapur, James A. Goldstein

October 31, 2017

Presentation TCT 2017

Cardiogenic Shock in the Elderly: Rational Treatment Suggestions

Presenter: Vladimir Dzavik, Navin K. Kapur, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

Cardiac Arrest With Cardiogenic Shock: Specific Management Considerations

Presenter: Vladimir Dzavik, Navin K. Kapur, Christian M. Spaulding

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of ECMO

Presenter: Vladimir Dzavik, Navin K. Kapur, Robb Kociol

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of Impella

Presenter: Vladimir Dzavik, Navin K. Kapur, Mark B. Anderson

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of IABP

Presenter: Vladimir Dzavik, Navin K. Kapur, David A Baran

October 31, 2017

Presentation TCT 2017

Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy?

Presenter: Vladimir Dzavik, Navin K. Kapur, Nicolas M. Van Mieghem

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: Pathophysiology, Hemodynamics, and Treatment Goals

Presenter: Vladimir Dzavik, Navin K. Kapur, Holger Thiele

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

Classifying Aortic Stenosis According to Pathophysiology and Hemodynamics An Echocardiographers Perspective

Presenter: Philippe Pibarot

October 30, 2017

Advertisement

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR)

First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease

Future Devices for Mechanical Circulatory Support in Cardiogenic Shock and High-Risk PCI

Novel Access Approaches for Percutaneous Maximal Circulatory Support Devices: Transcaval and Subclavian/Axillary Advancements

Mechanical Support Mishaps! Lessons Learned From Complications With Use of Mechanical Circulatory Support

An Algorithm for Mechanical Circulatory Support

Flash Perspectives: ECMO and ECMO Circuit Modifications Are the Best Methods to Achieve True Maximal Circulatory Support During High-Risk PCI!

Flash Debate: The Impella Series of Devices Is the Current Gold Standard for Mechanical Support During High-Risk PCI!

Flash Debate: An IABP Is Really All the Circulatory Support a Good Interventionalist Needs for Almost All Cases of High-Risk PCI!

When Should Hemodynamic Support Be Used During PCI?

Diagnosis and Treatment Options for RV Shock

Cardiogenic Shock in the Elderly: Rational Treatment Suggestions

Cardiac Arrest With Cardiogenic Shock: Specific Management Considerations

Acute Cardiogenic Shock: The Case for First-line Use of ECMO

Acute Cardiogenic Shock: The Case for First-line Use of Impella

Acute Cardiogenic Shock: The Case for First-line Use of IABP

Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy?

Acute Cardiogenic Shock: Pathophysiology, Hemodynamics, and Treatment Goals

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Classifying Aortic Stenosis According to Pathophysiology and Hemodynamics An Echocardiographers Perspective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content